Replies to post #4151 on Revance Therapeutics Inc (RVNC)

[edcoolidge]

I agree. There is a lot of truth to what you said because most market participants are short-term focused. We are also not in a very constructive market for loss-making companies with uncertain time to cash flow breakeven. Many would call that an opportunity.

[vinmantoo]

My guess is that Revance has gone through the transition from being an emerging biotech with a price based upon wishes dreams, and High Hopes to being an established biotech, whose price is based upon actual earnings and ROI.

Good analysis. Volume isn't particularly high today and that fits your comment.

The CD stream will not begin before next year. And with what the market has learned about the aesthetic stream, that’s going to be a very slow build up.

Fine with me. The bottom is in so now we wait for the slow but inexorable rise.